What Is the Recommended First IV/IO Dose of Lidocaine?
In the high-stakes environment of cardiac arrest or severe ventricular arrhythmias, every second and every milligram of medication counts. Lidocaine, a Class 1b antiarrhythmic, has been a cornerstone in advanced cardiac life support (ACLS) for decades, though its role has evolved. Understanding the precise, evidence-based first IV/IO dose of lidocaine is not just a memorization task for healthcare providers; it is a critical safety protocol that separates effective treatment from potential harm. The recommended initial dose is 1 to 1.5 milligrams per kilogram (mg/kg) of body weight, administered intravenously (IV) or intraosseously (IO) over a period of 2 to 3 minutes. This weight-based calculation is the non-negotiable standard, ensuring therapeutic effect while minimizing the risk of systemic toxicity, which can manifest as neurological impairment or cardiac depression. This article will provide a comprehensive, clinically-focused breakdown of this dosing, its rationale, administration technique, safety parameters, and its place in modern resuscitation algorithms.
The Clinical Context: Why Lidocaine and Why a Precise Dose?
Lidocaine works by blocking sodium channels in cardiac myocytes, stabilizing the cell membrane and suppressing abnormal automaticity and re-entrant circuits, particularly in ischemic or damaged ventricular tissue. Its primary ACLS indication is for the treatment of ventricular tachycardia (VT) or ventricular fibrillation (VF) that is refractory to defibrillation, or when a shockable rhythm persists despite initial shocks and epinephrine. It is also considered for stable monomorphic VT in certain scenarios.
The shift from a "one-size-fits-all" approach to a strict weight-based dosing (mg/kg) is fundamental. A flat dose (e.g., "100 mg") would be dangerously inappropriate for a 50 kg patient and subtherapeutic for a 120 kg patient. The 1-1.5 mg/kg range accounts for individual pharmacokinetic variability. The lower end (1 mg/kg) is often preferred for initial administration, especially in older patients or those with known hepatic impairment, as lidocaine is metabolized by the liver. The 1.5 mg/kg dose may be used for robust adults without contraindications when a more definitive effect is desired quickly. The absolute maximum first dose should not exceed 100-150 mg in most adult protocols, even if the calculated mg/kg dose is higher, to prevent acute toxicity.
Crucially, the route—whether intravenous (IV) or intraosseous (IO)—does not change the dose. The IO route provides rapid, reliable systemic delivery equivalent to a central IV line during cardiac arrest. Therefore, the recommended first IV/IO dose of lidocaine is identical: 1-1.5 mg/kg.
Step-by-Step: Calculating and Administering the First Dose
1. Accurate Weight Determination
The single most important step. In an emergency, use the last known weight, an estimated weight, or, if available, a measured weight. For obese patients, use lean body mass or actual body weight for initial dosing—there is no consensus to use adjusted body weight for the first dose in arrest, though some clinicians may consider it for repeat doses. Guessing is dangerous; if unsure, err on the side of a slightly lower dose (1 mg/kg) and be prepared to repeat if needed.
2. The Calculation
Formula: Patient's weight in kg x Dose (1.0 to 1.5) = Total milligrams (mg) to administer.
- Example for a 70 kg adult: 70 kg x 1.0 mg/kg = 70 mg. 70 kg x 1.5 mg/kg = 105 mg. The first dose would be between 70 mg and 105 mg, with 70-100 mg being a common practical range.
3. Preparation and Dilution
Lidocaine for cardiac arrest typically comes as 1% (10 mg/mL) or 2% (20 mg/mL) solution. For a 70 kg patient needing 100 mg:
- Using 1% (10 mg/mL): 100 mg / 10 mg/mL = 10 mL.
- Using 2% (20 mg/mL): 100 mg / 20 mg/mL = 5 mL. Best Practice: Dilute the calculated dose in a larger volume of compatible fluid (e.g., 10-20 mL of normal saline or D5W) in a syringe. This allows for a controlled, slower administration over the recommended 2-3 minutes and reduces the risk of local irritation if extravasation occurs.
4. Administration Technique
- Route: Administer via a large-bore IV catheter or a correctly placed IO needle.
- Rate: Push the diluted dose slowly over 2 to 3 minutes. Rapid bolus administration is a primary cause of acute toxicity, leading to seizures and cardiac depression.
- Monitoring: Continuously monitor the cardiac rhythm, blood pressure, and for any signs of neurological change (e.g., circumoral numbness, tinnitus, metallic taste, dizziness, muscle twitching, seizures).
5. Repeat Dosing and Maximum Cumulative Dose
If the arrhythmia persists, a repeat dose may be given. The repeat dose is typically 0.5 to 0.75 mg/kg.
- Critical Safety Limit: The total cumulative dose of lidocaine in a given hour should not exceed 3 mg/kg. This is the hard ceiling to prevent systemic toxicity. For a 70 kg patient, the absolute maximum in one hour would be 210 mg.
- Timing: Repeat doses are generally given 5-10 minutes after the initial dose, reassessing rhythm and clinical status.
Scientific Rationale and Pharmacokinetics
The 1-1.5 mg/kg IV/IO
